Archives of Pharmacal Research

, Volume 33, Issue 6, pp 925–932 | Cite as

Resveratrol inhibits dimethylnitrosamine-induced hepatic fibrosis in rats

  • Eun-Sil Lee
  • Mi-Ok Shin
  • Sik Yoon
  • Jeon-Ok MoonEmail author
Research Articles Drug Actions


Resveratrol, a phytoalexin found in grapes and red wines, has been reported to exhibit a wide range of pharmacological properties. In this study, we investigated the protective effect of resveratrol on hepatic injury induced by dimethylnitrosamine (DMN) in rats. Oral administration of resveratrol (20 mg/kg daily for 4 weeks) remarkably prevented the DMN-induced loss in body and liver weight, and inhibited the elevation of serum alanine transaminase, aspartate transaminase, alkaline phosphatase and bilirubin levels. Resveratrol also increased serum albumin and hepatic glutathione levels and reduced the hepatic level of malondialdehyde due to its antioxidant effect. Furthermore, DMN-induced elevation of hydroxyproline content was reduced in the resveratrol treated rats, the result of which was consistent with the reduction in type I collagen mRNA expression and the histological analysis of liver tissue stained with Sirius red. The reduction in hepatic stellate cell activation, as assessed by α-smooth muscle actin staining, and the reduction in transforming growth factor-β1 mRNA expression were associated with resveratrol treatment. In conclusion, resveratrol exhibited in vivo hepatoprotective and antifibrogenic effects against DMN-induced liver injury, suggesting that resveratrol may be useful in the prevention of the development of hepatic fibrosis.

Key words

Resveratrol Hepatoprotective effect Antifibrogenic effect Antioxidant effect Hepatic stellate cell TGF-β1 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ara, C., Kirimlioglu, H., Karabulut, A. B., Coban, S., Ay, S., Harputluoglu, M., and Yilmaz, S., Protective effect of resveratrol against oxidative stress in cholestasis. J. Surg. Res., 127, 112–117 (2005).CrossRefPubMedGoogle Scholar
  2. Athar, M., Back, J. H., Tang, X., Kim, H. K., Kopelovich, L., Bickers, D. R., and Kim, A. L., Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol. Appl. Pharmacol., 224, 274–283 (2007).CrossRefPubMedGoogle Scholar
  3. Bataller, R. and Brenner, D. A., Liver fibrosis. J. Clin. Invest., 115, 209–218 (2005).PubMedGoogle Scholar
  4. Buege, J. A. and Aust, S. D., Microsomal lipid peroxidation. Methods Enzymol., 52, 302–310 (1978).CrossRefPubMedGoogle Scholar
  5. Chávez, E., Reyes-Gordillo, K., Segovia, J., Shibayama, M., Tsutsumi, V., Vergara, P., Moreno, M. G., and Muriel, P., Resveratrol prevents fibrosis, NF-kappaB activation and TGF-beta increases induced by chronic CCl4 treatment in rats. J. Appl. Toxicol., 28, 35–43 (2008).CrossRefPubMedGoogle Scholar
  6. Friedman, S. L., Mechanisms of hepatic fibrogenesis. Gastroenterology, 134, 1655–1669 (2008a).CrossRefPubMedGoogle Scholar
  7. Friedman, S. L., Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev., 88, 125–172 (2008b)CrossRefPubMedGoogle Scholar
  8. Gasso, M., Rubio, M., Varela, G., Cabre, M., Caballeria, J., Alonso, E., Deulofem, R., Camps, J., Gimene, Z, A., Piares, M., Pares, A., Mato, J. M., and Rodes, J., Effects of S-adenosylmethionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis. J. Hepatol., 25, 200–205 (1996).CrossRefPubMedGoogle Scholar
  9. George, J., Roulot, D., Koteliansky, V. E., and Bissell, D. M., In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis. Proc. Natl. Acad. Sci. U.S.A., 96, 12719–12724 (1999).CrossRefPubMedGoogle Scholar
  10. Godichaud, S., Krisa, S., Couronne, B., Dubuisson, L., Merillon, J.-M., Desmouliere, A., and Rosenbaum, J., Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol. Hepatology, 31, 922–931 (2000).CrossRefPubMedGoogle Scholar
  11. Godichaud, S., Si-Tayeb, K., Auge, N,. Desmouliere, A., Balabaud, C., Payrastre, B., Negre-Salvayre, A., and Rosenbaum, J., The grape-derived polyphenol resveratrol differentially affects epidermal and platelet-derived growth factor signaling in human liver myofibroblasts. Int. J. Biochem. Cell Biol., 38, 629–637 (2006).CrossRefPubMedGoogle Scholar
  12. Haggerty, H. G. and Holsapple, M. P., Role of metabolism in dimethylnitrosamine-induced immunosuppression: A review. Toxicology, 63, 1–23 (1990).CrossRefPubMedGoogle Scholar
  13. Jezequel, A. M., Mancini, R., Ranaldesi, M. L., Balllardini, G., Fallani, M., Bianchi, F., and Orlandi, F., Dimethylnitrosamine-induced cirrhosis. Evidence for an immunological mechanism, J. Hepatol., 8, 42–52 (1989).CrossRefPubMedGoogle Scholar
  14. Junqueira, L. C., Bignolas, G., and Brentani, R. R., Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem. J., 11, 447–455 (1979).CrossRefPubMedGoogle Scholar
  15. Kawada, N., Seki, S., Inoue, M., and Kuroki, T., Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology, 27, 1265–1274 (1998).CrossRefPubMedGoogle Scholar
  16. Kolios, G., Valatas. V., and Kouroumalis E., Role of Kupffer cells in the pathogenesis of liver disease. World J. Gastroenterol., 14, 7413–7420 (2006).Google Scholar
  17. Lee, E. S., Lee, H. E., Shin, J. Y., Yoon, S., and Moon, J. O., The flavonoid quercetin inhibits dimethylnitrosamineinduced liver damage in rats. J. Pharm. Pharmcol., 55, 1169–1174 (2003).CrossRefGoogle Scholar
  18. Li, D. and Friedman, S. L., Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J. Gastroenterol. Hepatol., 14, 618–633 (1999).CrossRefPubMedGoogle Scholar
  19. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randal, R. J., Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265–275 (1951).PubMedGoogle Scholar
  20. Moreira, R. K., Hepatic stellate cells and liver fibrosis. Arch. Pathol. Lab. Med., 131, 1728–1734 (2007).PubMedGoogle Scholar
  21. Parola, M., Pinzani, M., Casini, A., Albano, E., Poli, G., Gentilini, A., Gentilini, P., and Dianzani, M. U., Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fatstoring cells. Biochem. Biophys. Res. Commun., 194, 1044–1050 (1993).CrossRefPubMedGoogle Scholar
  22. Rubiolo, J. A., Mithieux, G., and Vega, F. V., Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur. J. Pharmacol., 591, 66–72 (2008).CrossRefPubMedGoogle Scholar
  23. Shankar, S., Singh, G., and Srivastava, R. K., Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front. Biosci., 12, 4839–4854 (2007).CrossRefPubMedGoogle Scholar
  24. Terracini, B., Magee, P. N., and Barnes, J. M., Hepatic pathology in rats on low dietary levels of dimethylnitrosamine. Br. J. Cancer, 21, 559–565 (1967).PubMedGoogle Scholar
  25. Tsukamoto, H., Rippe, R., Niemela, O., and Lin, M., Role of oxidative stress in activation of Kupffer cell and Ito cells in liver fibrogenesis. J. Gastroenterol. Hepatol., 10, S50–S53 (1995).CrossRefPubMedGoogle Scholar
  26. Vendemiale, G., Grattagliano, I., Caruso, M. L., Serviddio, G., Valentini, A. M., Pirrelli, M., and Altomare, E., Increased oxidative stress in dimethylnitrosamine-induced liver fibrosis in the rat: effect of N-acetylcysteine and interferon-alpha. Toxicol. Appl. Pharmacol., 175, 130–139 (2001).CrossRefPubMedGoogle Scholar
  27. Wallace, K., Burt, A. D., and Wright, M. C., Liver fibrosis. Biochem. J., 411, 1–18 (2008).CrossRefPubMedGoogle Scholar
  28. Woessner, J. F. Jr., The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch. Biochem. Biophys., 93, 440–447 (1961).CrossRefPubMedGoogle Scholar
  29. Zhu, W. and Fung, P. C., The roles played by crucial free radicals like lipid free radicals, nitric oxide, and enzymes NOS and NADPH in CCl(4)-induced acute liver injury of mice. Free Radic. Biolic. Med., 29, 870–880 (2000).CrossRefGoogle Scholar

Copyright information

© The Pharmaceutical Society of Korea and Springer Netherlands 2010

Authors and Affiliations

  • Eun-Sil Lee
    • 1
  • Mi-Ok Shin
    • 1
    • 2
  • Sik Yoon
    • 3
  • Jeon-Ok Moon
    • 1
    Email author
  1. 1.College of PharmacyPusan National UniversityBusanKorea
  2. 2.Department of Food and NutritionSilla UniversityBusanKorea
  3. 3.Department of Anatomy, College of MedicinePusan National UniversityBusanKorea

Personalised recommendations